Filtros de búsqueda

Lista de obras de Ahmet Emre Eskazan

ABL gene kinase domain mutation scanning by denaturing high performance liquid chromatography sequencing method

artículo científico publicado en 2011

Acute Acalculous Cholecystitis due to Viral Hepatitis A

artículo científico publicado en 2013

Acute colitis presenting with hematochezia in a patient with chronic myeloid leukemia during dasatinib therapy.

artículo científico publicado en 2014

Additional chromosomal abnormalities at diagnosis or during tyrosine kinase inhibitor therapy in patients with chronic myeloid leukemia

artículo científico publicado en 2017

An alternative way - tyrosine kinase inhibitor (TKI) de-escalation - to discontinue TKIs in order to achieve treatment-free remission

artículo científico publicado en 2019

Assessment and Monitoring of Patients with Immune-Mediated Thrombotic Thrombocytopenic Purpura (iTTP): Strategies to Improve Outcomes

artículo científico publicado en 2020

Bone marrow transplantation for Behçet's disease: a case report and systematic review of the literature

artículo científico publicado en 2014

Bone-Specific Alkaline Phosphatase Levels among Patients with Multiple Myeloma Receiving Various Therapy Options

artículo científico publicado en 2014

Bortezomib therapy in patients with relapsed/refractory acquired thrombotic thrombocytopenic purpura

artículo científico publicado en 2016

Bosutinib - an effective and safe treatment option in the management of chronic myeloid leukemia

scientific article published on 10 January 2020

Bosutinib - related pleural effusion in patients with chronic myeloid leukemia

artículo científico publicado en 2020

Brucellar pericarditis: a report of four cases and review of the literature.

artículo científico

COVID-19 presenting with immune thrombocytopenia: a case report and review of the literature

scientific article published on 04 June 2020

Can Positron Emission Tomography and Computed Tomography Be a Substitute for Bone Marrow Biopsy in Detection of Bone Marrow Involvement in Patients with Hodgkin's or Non-Hodgkin's Lymphoma?

artículo científico publicado en 2015

Chronic lymphocytic leukemia developing in a patient with Janus kinase 2 V617F mutation positive myeloproliferative neoplasm

artículo científico publicado en 2011

Chronic myeloid leukemia and the use of tyrosine kinase inhibitors in the days of COVID-19 pandemic

scientific article published on 07 May 2020

Chronic myeloid leukemia patients who develop grade I/II pleural effusion under second-line dasatinib have better responses and outcomes than patients without pleural effusion.

artículo científico publicado en 2014

Chronic myeloid leukemia patients with F317L BCR-ABL kinase domain mutation are resistant to dasatinib: is that true for all the patients?

artículo científico publicado en 2011

Clinical Outcomes Related to the Use of Bendamustine Therapy for Multiple Myeloma Patients Relapsed/Refractory to Immunomodulatory Drugs and Proteasome Inhibitors

artículo científico publicado en 2017

Co-administration of cyclosporine A and imatinib among patients with Philadelphia chromosome-positive leukemias in the post-transplant setting

artículo científico publicado en 2016

Coexistence of Hermansky-Pudlak syndrome and JAK2V617F-positive essential thrombocythemia

artículo científico publicado en 2019

Comment and response to: the significance of early warning in chronic myeloid leukemia

artículo científico publicado en 2017

Comparison of International Prognostic Index and NCCN-IPI in 324 patients with de novo diffuse large B-cell lymphoma: a multi-center retrospective analysis

artículo científico publicado en 2015

Congenital Dyserythropoietic Anemia Type 1: Report of One Patient and Analysis of Previously Reported Patients Treated with Interferon Alpha

artículo científico publicado en 2015

Copy number variations in adult patients with chronic immune thrombocytopenia

scientific article published on 04 September 2020

Critical appraisal of European LeukemiaNet (ELN) 2013 recommendations for the management of chronic myeloid leukemia: is it early for a warning?

artículo científico publicado en 2016

Cyclosporin A therapy on idiopathic thrombotic thrombocytopenic purpura in the relapse setting: two case reports and a review of the literature.

artículo científico publicado en 2012

Cytopenia in adult brucellosis patients.

artículo científico publicado en 2018

Dasatinib May Override F317L BCR-ABL Kinase Domain Mutation in Patients with Chronic Myeloid Leukemia

artículo científico publicado en 2013

Dasatinib for the treatment of chronic myeloid leukemia: patient selection and special considerations

artículo científico publicado en 2016

Dasatinib-Induced Pulmonary Arterial Hypertension

artículo científico publicado en 2018

Deep sequencing of BCR-ABL1 kinase domain mutations in chronic myeloid leukemia patients with resistance to tyrosine kinase inhibitors

artículo científico publicado en 2018

Detailed analysis of diffuse large B cell lymphoma patients: a single-center, retrospective study

artículo científico publicado en 2013

Do all patients with chronic myeloid leukemia need to receive interferon during pregnancy?

scientific article published on 16 January 2017

Does switching to a second-generation tyrosine kinase inhibitor or increasing imatinib dose have long-term benefits in chronic myeloid leukemia patients with suboptimal responses under upfront standard-dose of imatinib?

article

Essential thrombocythemia and multiple myeloma: two rare diseases in one patient

artículo científico publicado en 2011

Evolving treatment strategies in CML - moving from early and deep molecular responses to TKI discontinuation and treatment-free remission: is there a need for longer-term trial outcomes?

artículo científico publicado en 2018

First line treatment of chronic phase chronic myeloid leukaemia patients with the generic formulations of imatinib mesylate

artículo científico publicado en 2014

Follicular lymphoma generating in a patient with non-small cell lung cancer following nivolumab discontinuation

scientific article published on 16 April 2020

Further augmentation of molecular responses with dasatinib therapy in chronic myeloid leukemia patients who gained major molecular response under imatinib

artículo científico publicado en 2017

Generic imatinib in the treatment of chronic myeloid leukemia: Cerrahpaşa experience

artículo científico publicado en 2015

Generics in chronic myeloid leukemia: current arguments for and against and the established evidence

artículo científico publicado en 2014

Hypereosinophilic syndrome associated with simultaneous intracardiac thrombi, cerebral thromboembolism and pulmonary embolism

artículo científico publicado en 2012

Idasanutlin as a new treatment option in improving the therapeutic odyssey of relapsed/refractory AML

scientific article published on 27 April 2020

Imatinib mesylate in the management of chemotherapy-induced pulmonary toxicity: a double-edged sword

artículo científico publicado en 2018

Imatinib reduces bone marrow fibrosis and overwhelms the adverse prognostic impact of reticulin formation in patients with chronic myeloid leukaemia.

artículo científico publicado en 2016

Interstitial pneumonitis in a patient with chronic myeloid leukemia

artículo científico publicado en 2013

Intracranial extramedullary hematopoiesis in patients with thalassemia: a case report and review of the literature.

artículo científico

Intracranial mass in a patient with thalassaemia major

scientific article published on 23 November 2010

Is it beneficial to use hydroxychloroquine and imatinib combination in order to achieve deeper molecular responses in patients with chronic myeloid leukemia?

artículo científico publicado en 2020

Is measuring plasma imatinib trough levels still an appropriate way for predicting responses in patients with chronic myeloid leukemia?

scientific article published on 04 February 2019

Moving on from 2013 to 2020 European LeukemiaNet recommendations for treating chronic myeloid leukemia: what has changed over the 7 years?

artículo científico publicado en 2020

New drugs approved for acute myeloid leukaemia in 2018

scientific article published on 13 December 2019

Novel therapeutic approaches in chronic myeloid leukemia

artículo científico publicado en 2020

Outcomes of Chronic Myeloid Leukemia Patients With Early Molecular Response at 3 and 6 Months: A Comparative Analysis of Generic Imatinib and Glivec.

artículo científico publicado en 2017

Platelet count threshold for lumbar puncture: Does one size really fit all?

artículo científico publicado en 2020

Pleural and pericardial effusions in chronic myeloid leukemia patients receiving low-dose dasatinib therapy.

artículo científico publicado en 2011

Pleural tuberculosis in a patient with untreated type 1 Gaucher disease

artículo científico publicado en 2015

Postoperative thrombotic thrombocytopenic purpura

artículo científico publicado en 2013

Primary cutaneous immunocytoma/marginal zone B-cell lymphoma: a case with unusual course

artículo científico publicado en 2004

Primary gastrointestinal diffuse large B cell lymphoma presenting with cold agglutinin disease.

artículo científico publicado en 2011

Radotinib and its clinical potential in chronic-phase chronic myeloid leukemia patients: an update.

artículo científico publicado en 2017

Radotinib in the treatment of chronic phase chronic myeloid leukemia patients

artículo científico publicado en 2015

Relapse after allogeneic hematopoietic stem cell transplant in patients with chronic myeloid leukemia: tyrosine kinase inhibitors, donor lymphocyte infusions or both?

artículo científico publicado en 2015

Replacing chemotherapy with arsenic trioxide for the treatment of acute promyelocytic leukemia in the frontline setting: Is it cost-effective?

artículo científico publicado en 2019

Retrospective Evaluation of Hairy Cell Leukemia Patients Treated with Three Different First-Line Treatment Modalities in the Last Two Decades: A Single-Center Experience.

artículo científico publicado en 2017

Sarcoidosis mimicking lymphoma on positron emission tomography-computed tomography in two patients treated for lymphoma: two case reports

scientific article published on 23 June 2009

Second primary malignancies in chronic myeloid leukemia patients

artículo científico publicado en 2015

Second-Line Nilotinib Treatment in Patients With Chronic Myeloid Leukemia in a Developing Country

artículo científico publicado en 2016

Secondary Infections in Febrile Neutropenia in Hematological Malignancies: More Than Another Febrile Neutropenic Episode.

artículo científico publicado en 2015

Simultaneous detection of B-cell chronic lymphocytic leukemia and colon adenocarcinoma in the same mesenteric lymph node.

artículo científico publicado en 2013

Spondylodiscitis: evaluation of patients in a tertiary hospital

artículo científico publicado en 2014

Starting with a lower daily dose of dasatinib in patients with chronic myeloid leukemia in chronic phase: Less is more, or is it?

artículo científico publicado en 2018

Successful management of chronic refractory immune thrombocytopenia with laparoscopic splenectomy in a patient with acute promyelocytic leukemia

artículo científico publicado en 2012

The Association Between JAK2V617F Mutation and Bone Marrow Fibrosis at Diagnosis in Patients with Philadelphia-Negative Chronic Myeloproliferative Neoplasms.

artículo científico publicado en 2012

The Changing Epidemiology of Bloodstream Infections and Resistance in Hematopoietic Stem Cell Transplantation Recipients

artículo científico publicado en 2015

The Impact and Prognostic Significance of Chronic Lymphocytic Leukemia Upregulated 1 (CLLU1) Gene Expression in Patients with Chronic Lymphocytic Leukemia: A Single Center Experience

scientific article published on 27 September 2019

The Outcomes of Chronic Myeloid Leukemia Patients With Molecular Warning Responses During Imatinib Treatment According to the European LeukemiaNet 2013 Recommendations

artículo científico publicado en 2019

The current situation and future aspects of cost-effectiveness in chronic myeloid leukemia treatment.

artículo científico publicado en 2014

The efficacy and tolerability issue of generics of imatinib in the treatment of chronic myeloid leukemia: do generics really jeopardize patient safety?

artículo científico publicado en 2014

The efficacy of generic formulations of imatinib mesylate in the treatment of chronic myeloid leukemia

artículo científico publicado en 2014

The impact of BCR-ABL1 transcript type on tyrosine kinase inhibitor responses and outcomes in patients with chronic myeloid leukemia.

artículo científico publicado en 2018

The issue of financial toxicity in the management of chronic myeloid leukemia with blast crisis

artículo científico publicado en 2018

The tolerability issue of generic imatinib in patients with chronic myeloid leukemia (Comment on Adi J. Klil-Drori et al., Haematologica 2019;104(7):e293)

artículo científico publicado en 2019

Therapy-related chronic myeloid leukemia in a patient receiving peptide receptor radionuclide therapy for pancreatic neuroendocrine tumor

artículo científico publicado en 2020

Third-line treatment with second-generation tyrosine kinase inhibitors (dasatinib or nilotinib) in patients with chronic myeloid leukemia after two prior TKIs: real-life data on a single center experience along with the review of the literature.

artículo científico publicado en 2017

Thrombotic thrombocytopenic purpura after prophylactic cefuroxime axetil administered in relation to a liposuction procedure

artículo científico publicado en 2011

Treatment and Outcome of Primary and Secondary Thrombotic Microangiopathies

scientific article published on 14 July 2015

Treatment of patients with immune thrombocytopenia admitted to the emergency room

artículo científico publicado en 2016

Turkish Chronic Myeloid Leukemia Study: Retrospective Sectional Analysis of CML Patients.

scientific article published on 05 December 2013

Two cases of autoimmune hemolytic anemia secondary to brucellosis: a review of hemolytic disorders in patients with brucellosis

artículo científico publicado en 2014

Tyrosine Kinase Inhibitor Sequencing in Patients with Chronic Myeloid Leukemia

artículo científico publicado en 2019

Tyrosine Kinase Inhibitor-Associated Platelet Dysfunction: Does This Need to Have a Significant Clinical Impact?

artículo científico publicado en 2019

Tyrosine kinase inhibitor (TKI) therapy for newly-diagnosed patients with chronic myeloid leukemia: focusing on TKI discontinuation due to adverse events - is better always good?

artículo científico publicado en 2017

Tyrosine kinase inhibitors (TKIs) used in the management of chronic myeloid leukaemia are associated with haematologic toxicities-Which TKI is the safest?

scientific article published on 22 August 2019

Upfront nilotinib therapy among patients with chronic myeloid leukemia in chronic phase

artículo científico publicado en 2017

Variant Philadelphia translocations with different breakpoints in six chronic myeloid leukemia patients

artículo científico publicado en 2011

Vascular Adverse Events During Long-term Nilotinib Therapy in Patients With Chronic Myeloid Leukemia

artículo científico publicado en 2017

Vincristine as an Adjunct to Therapeutic Plasma Exchange for Thrombotic Thrombocytopenic Purpura: A Single-Institution Experience

artículo científico publicado en 2018

Dominio Público Uruguay está sostenido por:

Acerca de Dominio Público Uruguay

Ayuda